Enrique Esteve Valverde, MD, PhD retweeted
🗣️ Olga Pané: "La IA és extraordinàriament efectiva i diagnostica amb una precisió igual o superior a la dels professionals"
❌ La consellera de @salutcat ha de rectificar de manera pública i immediata, o deixar el càrrec.
Enrique Esteve Valverde, MD, PhD retweeted
𝗠𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺𝘀 𝗼𝗳 𝗔𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗧𝗲𝘀𝘁𝗼𝘀𝘁𝗲𝗿𝗼𝗻𝗲
Many of the benefits and some of the risks of testosterone treatment are mediated by the mechanisms through which testosterone acts. Testosterone has anabolic effects on muscle (panel A) and bone (panel B) and stimulates erythropoiesis (panel C) through androgen receptor–mediated mechanisms. Nongenomic mechanisms of action increase penile blood flow and improve erectile function (panel D). The effects of testosterone on sexual desire and bone are mediated largely through its conversion to 17β-estradiol. Testosterone is also converted to dihydrotestosterone (DHT), which stimulates prostate growth and has additional anabolic effects on muscle and bone. Testosterone and DHT increase penile blood flow and erections through a rapid increase in the production of nitric oxide, which is endothelium-dependent, as well as through inhibition of voltage-operated l-type calcium channels, activation of potassium channels on smooth muscle, or both mechanisms, which are endothelium-independent (panel D). A metabolite of DHT, 5α-androstane-3α,17β-diol, which is a ligand for the γ-aminobutyric acid receptor, has been linked to mood and affect.
Learn more in the Review Article “Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism” by Shalender Bhasin, MB, BS, and Peter J. Snyder, MD, from @BrighamWomens, @harvardmed, and @PennMedicine: nej.md/4ooeFo7
Enrique Esteve Valverde, MD, PhD retweeted
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS - Developed by the International VEXAS Working Group Expert Panel
Figure: A practical treatment algorithm for clinical management of VEXAS syndrome based on current available evidence
Enrique Esteve Valverde, MD, PhD retweeted
🧵 Red Eye in Rheumatology — When It’s Not “Just Conjunctivitis”
In rheumatology, a red eye can mean systemic inflammation, vasculitis, or a vision-threatening flare.
Here’s how to tell benign from dangerous — fast. 👇
@IhabFathiSulima @DrAkhilX @CelestinoGutirr #MedTwitter #NEETPG
Enrique Esteve Valverde, MD, PhD retweeted
A table summarizing common coagulation tests, their measures, conditions under which they are prolonged or normal, and the interpretation of results for likely diagnoses.
anesthguide.com/topic/coagul…
Enrique Esteve Valverde, MD, PhD retweeted
New content online: Platelets as drivers of immunothrombosis in rheumatic diseases bit.ly/4nAhTED
Enrique Esteve Valverde, MD, PhD retweeted
🔴 NEW EULAR recommendations for #SLE with #kidney involvment (2025)!
➡️ early biopsy
➡️ early combination
➡️ non immune treatment
#EULAR2025
Enrique Esteve Valverde, MD, PhD retweeted
Good talk! Important slide.The monoclonal protein is usually a clue to the diagnosis 👇
#EULAR2025 #Rheumatology #MedTwitter
Enrique Esteve Valverde, MD, PhD retweeted
Histologic features of Antiphospholipid #EULAR2025
Enrique Esteve Valverde, MD, PhD retweeted
🔬Cancer risk in #Scleroderma
🧬 20% cancer prevalence in SSc patients
⏫ Higher risk in elderly & anti-Ro52 or U3-RNP antibodies
📍 Cancer-associated SSc is linked to the absence of anti-centromere & topoisomerase-1 antibodies
🔓 rmdopen.bmj.com/content/10/3…
Enrique Esteve Valverde, MD, PhD retweeted
Hematology residents, a lot of times we get confused as to what is light chain, heavy chain and free light chain with regards to myeloma? What is IgA, IgG,etc and likewise whats kappa and lambda exactly.
If you have the same question, you are in the right place.
Image source: Health Tree.
Enrique Esteve Valverde, MD, PhD retweeted
#MedicinaInterna | @Sociedad_SEMI actualiza las novedades en el abordaje de #enfermedades autoinmunes
buff.ly/3zqebcB
Enrique Esteve Valverde, MD, PhD retweeted
Un placer haber participado junto a mis compañeros en la reunión del Grupo de Enfermedades Autoinmunes Sistémicas #GEAS2024 #17GEAS #Enfermedadesautoinmunes #parctauli @gtgeassemi @autoinMI_tauli @javidlcid @andreafernii @emegargon @bmarialfonso @cfeijoo5 @EsteveDoctor
Enrique Esteve Valverde, MD, PhD retweeted
😎Approach to elevated Ferritin
@bmj_latest
Enrique Esteve Valverde, MD, PhD retweeted
📢🗞️📰#17GEAS #GEAS2024 | Más de 300 médicos internistas del país analizan en Málaga novedades en enfermedades autoinmunes sistémicas
lavozdemalaga.com/mas-de-300…
@gtgeassemi @DrGlezGarcia @CarreteroJuani @herranz_maite @JoseMPorcel @mendez_bailon #SEMITuit #MedicinaInterna
Enrique Esteve Valverde, MD, PhD retweeted
Algoritmos de cribado en las manifestaciones extra🫁 en #sarcoidosis presentado por Dr. Carlos Feijoo en #geas24 @gtgeassemi @parctauli @Sociedad_SEMI @I3ptT @SarcoidosisNews @sarcoid_papers
Enrique Esteve Valverde, MD, PhD retweeted
Guidelines on the investigation and management of antiphospholipid syndrome
⏩Clinical diagnosis
⏩Laborarory Diagnosis
⏩Management of Trombosis APS
⏩Obstetric APS
⏩Catastrophic APS
⏩Management of persistently + APL carriers
onlinelibrary.wiley.com/doi/…
Enrique Esteve Valverde, MD, PhD retweeted
🔥 One of the most important articles of the year showing medical evidence for disease-modifying (organ damage prevention) therapies in #SLE #lupus:
CLICK 👉 lupus.bmj.com/content/11/1/e…
Kudos to the authors for such an important piece of work. Open up the table in the article and pay attention to which gets lots of green dots (best) and which gets lots of red dots (worst)
@Lupus_SM @Lupusdoc and all the authors!
Enrique Esteve Valverde, MD, PhD retweeted
Suspected inflammatory rheumatic diseases in patients presenting with skin rashes
🚨Review
⏩highly variable
⏩High suspicion is needed
⏩Detailed clinical skin observation can be more useful than a biopsy.
⏩Recognize it
sciencedirect.com/science/ar…

















































